Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials.

Vesikari T, Esposito S, Prymula R, Ypma E, Kohl I, Toneatto D, Dull P, Kimura A; EU Meningococcal B Infant Vaccine Study group.

Lancet. 2013 Mar 9;381(9869):825-35. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

PMID:
23324563
2.

Multicomponent meningococcal serogroup B vaccine (4CMenB; Bexsero(®)): a review of its use in primary and booster vaccination.

Carter NJ.

BioDrugs. 2013 Jun;27(3):263-74. doi: 10.1007/s40259-013-0029-2. Review.

PMID:
23575646
3.

Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infection.

McIntosh ED, Carey V, Toneatto D, Dull P, Wassil J.

Ther Adv Vaccines. 2015 Jan;3(1):13-23. doi: 10.1177/2051013614557477. Review.

4.

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.

Dhillon S.

Drugs. 2010 May 28;70(8):1021-58. doi: 10.2165/11204830-000000000-00000. Review.

PMID:
20481658
5.

Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).

Dhillon S.

BioDrugs. 2010 Oct 1;24(5):299-302. doi: 10.2165/11206690-000000000-00000. Review.

PMID:
20795752
6.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
7.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
8.

Needle size for vaccination procedures in children and adolescents.

Beirne PV, Hennessy S, Cadogan SL, Shiely F, Fitzgerald T, MacLeod F.

Cochrane Database Syst Rev. 2015 Jun 18;(6):CD010720. doi: 10.1002/14651858.CD010720.pub2. Review.

PMID:
26086647
9.

The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.

Mameli C, Galli E, Mantegazza C, Fabiano V, Zuccotti GV.

Future Microbiol. 2015;10(10):1579-98. doi: 10.2217/fmb.15.91. Epub 2015 Oct 6. Review.

PMID:
26437903
10.

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers.

Esposito S, Tagliabue C, Bosis S.

J Immunol Res. 2015;2015:402381. doi: 10.1155/2015/402381. Epub 2015 Aug 17. Review.

11.

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.

Medini D, Stella M, Wassil J.

Vaccine. 2015 May 28;33(23):2629-36. doi: 10.1016/j.vaccine.2015.04.015. Epub 2015 Apr 13. Review.

12.

Group B meningococcal vaccine science and policy.

Drysdale SB, Pollard AJ.

J Infect. 2015 Jun;71 Suppl 1:S15-20. doi: 10.1016/j.jinf.2015.04.021. Epub 2015 Apr 24. Review.

PMID:
25917798
13.

Challenges in vaccination of neonates, infants and young children.

Pichichero ME.

Vaccine. 2014 Jun 30;32(31):3886-94. doi: 10.1016/j.vaccine.2014.05.008. Epub 2014 May 14. Review.

14.

Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations.

Rosen JB, Breman JG.

Lancet. 2004 Apr 24;363(9418):1386-8. Review.

PMID:
15110499
15.

Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Marín AC, Gisbert JP, Chaparro M.

World J Gastroenterol. 2015 Oct 28;21(40):11273-81. doi: 10.3748/wjg.v21.i40.11273. Review.

16.

Vaccine administration in children with chronic kidney disease.

Esposito S, Mastrolia MV, Prada E, Pietrasanta C, Principi N.

Vaccine. 2014 Nov 20;32(49):6601-6. doi: 10.1016/j.vaccine.2014.09.038. Review.

PMID:
25275950
17.

The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health.

Ladhani SN, Campbell H, Parikh SR, Saliba V, Borrow R, Ramsay M.

J Infect. 2015 Dec;71(6):611-4. doi: 10.1016/j.jinf.2015.09.035. Epub 2015 Oct 2. Review.

PMID:
26433141
18.

Vaccines for prevention of group B meningococcal disease: Not your father's vaccines.

Harrison LH.

Vaccine. 2015 Nov 27;33 Suppl 4:D32-8. doi: 10.1016/j.vaccine.2015.05.101. Epub 2015 Jul 2. Review.

PMID:
26116255
19.

The genetic regulation of infant immune responses to vaccination.

Newport MJ.

Front Immunol. 2015 Feb 2;6:18. doi: 10.3389/fimmu.2015.00018. eCollection 2015. Review.

20.

Vaccinations in paediatric rheumatology: an update on current developments.

Groot N, Heijstek MW, Wulffraat NM.

Curr Rheumatol Rep. 2015 Jul;17(7):46. doi: 10.1007/s11926-015-0519-y. Review.

Items per page

Supplemental Content

Write to the Help Desk